Patent Assignment
Reel/Frame 018902/0870
Assignment of Assignor's Interest
Recorded: 2007-02-19
Pages: 3
Assignor
SIRBASKU, DAVID A., PHD
Executed: 2007-02-19
Assignee
SIGNE BIOPHARMA INC.
1701 S. HIGHWAY 121 BUSINESS, SUITE 301, LEWISVILLE, TEXAS, 75067
Covered Properties
(5)
Compositions and Methods for the Diagnosis, Treatment and Prevention of Steroid Hormone Responsive Cancers
Compositions and Methods for Demonstrating Secretory Immune System Regulation of Steroid Hormone Responsive Cancer Cell Growth
Breast cancer eradication program
Application:
10/293,019 →
Publication:
US 2003/0072812
Anti-Estrogen and Immune Modulator Combinations for Treating Breast Cancer
Screening Method for Predicting Susceptibility to Breast Cancer
Related Assignments
(10)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 18, 2002
From: UNIVERSITY OF TEXAS SYSTEM, THE
To: SIRBASKU, DAVID A.
Reel/Frame 012731/0072 →
Assignment of Assignor's Interest
Mar 18, 2002
From: UNIVERSITY OF TEXAS SYSTEM, THE
To: SIRBASKU, DAVID A.
Reel/Frame 012731/0181 →
Assignment of Assignor's Interest
Feb 10, 2003
From: UNIVERSITY OF TEXAS SYSTEM, THE
To: SIRBASKU, DAVID A.
Reel/Frame 013738/0098 →
Assignment of Assignor's Interest
Feb 10, 2003
From: UNIVERSITY OF TEXAS SYSTEMS, THE
To: SIRBASKU, DAVID A.
Reel/Frame 013737/0951 →
Assignment of Assignor's Interest
Feb 10, 2003
From: UNIVERSITY OF TEXAS SYSTEM, THE
To: SIRBASKU, DAVID A.
Reel/Frame 013737/0963 →
Confirmatory Licenses for Government Register
Apr 22, 2004
From: KAYLONE BIOPHARMACEUTICALS
To: UNITED STATES GOVERNMENT SECRETARY OF THE ARMY, THE
Reel/Frame 015233/0181 →
Change of Assignee Address
Sep 5, 2007
From: SIGNE BIOPHARMA INC.
To: SIGNE BIOPHARMA INC.
Reel/Frame 019785/0099 →
Assignment of Assignor's Interest
Jan 30, 2012
From: SIRBASKU, DAVID A
To: SIGNE BIOPHARMA INC.
Reel/Frame 027618/0108 →
Assignment of Assignor's Interest
Jan 30, 2012
From: SIRBASKU, DAVID A
To: SIGNE BIOPHARMA INC.
Reel/Frame 027618/0021 →
Assignment of Assignor's Interest
Jan 30, 2012
From: SIRBASKU, DAVID A
To: SIGNE BIOPHARMA INC.
Reel/Frame 027617/0906 →